Advanced search

Vol 58, No 3 (2024)
Review Article
Published online: 2024-06-12

open access

View PDF Download PDF file
Page views 227
Article views/downloads 106
Get Citation

Connect on Social Media

Connect on Social Media

Deep brain stimulation of anterior nucleus and centromedian nucleus of thalamus in treatment for drug-resistant epilepsy

Michał Sobstyl1, Magdalena Konopko2, Aleksandra Wierzbicka3, Marek Prokopienko1, Tadeusz Pietras4, Kasper Sipowicz5
DOI: 10.5603/pjnns.98258
Pubmed: 38864766
Neurol Neurochir Pol 2024;58(3):256-273.

Abstract

Introduction. Drug-resistant epilepsy (DRE) remains poorly-controlled in c.33% of patients, and up to 50% of patients suffering from DRE are deemed not to be suitable candidates for resective surgery. For these patients, deep brain stimulation (DBS) may constitute the last resort in the treatment of DRE.

State of the art. We undertook a systematic review of the current literature on DBS efficacy and the safety of two thalamic nuclei–anterior nucleus of the thalamus (ANT) and the centromedian nucleus of the thalamus in the management of patients with DRE. A search using two electronic databases, the Medical Literature, Analysis, and Retrieval System on-line (MEDLINE) and the Cochrane Central Register of Controlled Trials (CEN-TRAL) was conducted.

Clinical implications. We found 30 articles related to ANT DBS and 13 articles related to CMN DBS which were further analysed. Based on the clinical research articles, we found a mean seizure frequency reduction for both thalamic nuclei. For ANT DBS, the mean seizure frequency reduction ranged from 48% to 75%, and for CMN DBS from 46.7% to 91%. The responder rate (defined as at least 50% reduction in seizure frequency) was reported to be 53.2-75% for patients after ANT DBS and 50-90% for patients after CMN DBS.

Future directions. ANT and CMN DBS appear to be safe and efficacious treatments, particularly in patients with refractory partial seizures and primary generalised seizures. ANT DBS reduces most effectively seizures originating in the temporal and frontal lobes. CMN DBS reduces mostly primary generalised tonic-clonic and atypical absences and atonic seizures. Seizures related to Lennox-Gastaut syndrome respond very favourably to CMN DBS.

Keywords: deep brain stimulationthalamic stimulationdrug-resistant epilepsyanterior nucleus of the thalamuscentromedian nucleus of the thalamusneuromodulation

Article available in PDF format

View PDF Download PDF file

References

  1. Kwan P, Brodie MJ. Early identification of refractory epilepsy. N Engl J Med. 2000; 342(5): 314–319.
    CrossRefPubMed
  2. Brodie MJ, Dichter MA, Brodie MJ. Established antiepileptic drugs. Seizure. 1997; 6(3): 159–174.
    CrossRefPubMed
  3. Téllez-Zenteno JF, Dhar R, Wiebe S. Long-term seizure outcomes following epilepsy surgery: a systematic review and meta-analysis. Brain. 2005; 128(Pt 5): 1188–1198.
    CrossRefPubMed
  4. Cramer SW, McGovern RA, Wang SG, et al. Resective epilepsy surgery: assessment of randomized controlled trials. Neurosurg Rev. 2021; 44(4): 2059–2067.
    CrossRefPubMed
  5. Ma BB, Rao VR. Responsive neurostimulation: Candidates and considerations. Epilepsy Behav. 2018; 88: 388–395.
    CrossRefPubMed
  6. Geller EB, Skarpaas TL, Gross RE, et al. Brain-responsive neurostimulation in patients with medically intractable mesial temporal lobe epilepsy. Epilepsia. 2017; 58(6): 994–1004.
    CrossRefPubMed
  7. Fisher R, Salanova V, Witt T, et al. SANTE Study Group. Electrical stimulation of the anterior nucleus of thalamus for treatment of refractory epilepsy. Epilepsia. 2010; 51(5): 899–908.
    CrossRefPubMed
  8. Fisher RS. Deep brain stimulation of thalamus for epilepsy. Neurobiol Dis. 2023; 179: 106045.
    CrossRefPubMed
  9. McInnes MDF, Moher D, Thombs BD, et al. Preferred Reporting Items for a Systematic Review and Meta-analysis of Diagnostic Test Accuracy Studies: The PRISMA-DTA Statement. JAMA. 2018; 319(4): 388–396.
    CrossRefPubMed
  10. Upton AR, Cooper IS, Springman M, et al. Suppression of seizures and psychosis of limbic system origin by chronic stimulation of anterior nucleus of the thalamus. Int J Neurol. 1985; 19-20: 223–230.
    PubMed
  11. Kerrigan JF, Litt B, Fisher RS, et al. Electrical stimulation of the anterior nucleus of the thalamus for the treatment of intractable epilepsy. Epilepsia. 2004; 45(4): 346–354.
    CrossRefPubMed
  12. Child ND, Benarroch EE, et al. Anterior nucleus of the thalamus: functional organization and clinical implications. Neurology. 2013; 81(21): 1869–1876.
    CrossRefPubMed
  13. Hodaie M, Wennberg RA, Dostrovsky JO, et al. Chronic anterior thalamus stimulation for intractable epilepsy. Epilepsia. 2002; 43(6): 603–608.
    CrossRefPubMed
  14. Klinger NV, Mittal S, et al. Clinical efficacy of deep brain stimulation for the treatment of medically refractory epilepsy. Clin Neurol Neurosurg. 2016; 140: 11–25.
    CrossRefPubMed
  15. Lim SN, Lee ST, Tsai YT, et al. Electrical stimulation of the anterior nucleus of the thalamus for intractable epilepsy: a long-term follow-up study. Epilepsia. 2007; 48(2): 342–347.
    CrossRefPubMed
  16. Osorio I, Overman J, Giftakis J, et al. High frequency thalamic stimulation for inoperable mesial temporal epilepsy. Epilepsia. 2007; 48(8): 1561–1571.
    CrossRefPubMed
  17. Andrade DM, Zumsteg D, Hamani C, et al. Long-term follow-up of patients with thalamic deep brain stimulation for epilepsy. Neurology. 2006; 66(10): 1571–1573.
    CrossRefPubMed
  18. Lee KJ, Shon YM, Cho CB. Long-term outcome of anterior thalamic nucleus stimulation for intractable epilepsy. Stereotact Funct Neurosurg. 2012; 90(6): 379–385.
    CrossRefPubMed
  19. Salanova V, Witt T, Worth R, et al. SANTE Study Group. Long-term efficacy and safety of thalamic stimulation for drug-resistant partial epilepsy. Neurology. 2015; 84(10): 1017–1025.
    CrossRefPubMed
  20. Salanova V, Sperling MR, Gross RE, et al. SANTÉ Study Group. The SANTÉ study at 10 years of follow-up: Effectiveness, safety, and sudden unexpected death in epilepsy. Epilepsia. 2021; 62(6): 1306–1317.
    CrossRefPubMed
  21. Kim SH, Lim SC, Kim J, et al. Long-term follow-up of anterior thalamic deep brain stimulation in epilepsy: A 11-year, single center experience. Seizure. 2017; 52: 154–161.
    CrossRefPubMed
  22. Krishna V, King NK, Sammartino F, et al. Anterior Nucleus Deep Brain Stimulation for Refractory Epilepsy: Insights Into Patterns of Seizure Control and Efficacious Target. Neurosurgery. 2016; 78(6): 802–811.
    CrossRefPubMed
  23. Lee KJ, Jang KS, Shon YM, et al. Chronic deep brain stimulation of subthalamic and anterior thalamic nuclei for controlling refractory partial epilepsy. Acta Neurochir Suppl. 2006; 99: 87–91.
    CrossRefPubMed
  24. Sitnikov AR, Grigoryan YuA, Mishnyakova LP. Bilateral stereotactic lesions and chronic stimulation of the anterior thalamic nuclei for treatment of pharmacoresistant epilepsy. Surg Neurol Int. 2018; 9: 137.
    CrossRefPubMed
  25. Piacentino M, Durisotti C, Garofalo PG, et al. Anterior thalamic nucleus deep brain Stimulation (DBS) for drug-resistant complex partial seizures (CPS) with or without generalization: long-term evaluation and predictive outcome. Acta Neurochir (Wien). 2015; 157(9): 1525–32; discussion 1532.
    CrossRefPubMed
  26. Herrman H, Egge A, Konglund AE, et al. Anterior thalamic deep brain stimulation in refractory epilepsy: A randomized, double-blinded study. Acta Neurol Scand. 2019; 139(3): 294–304.
    CrossRefPubMed
  27. Park HR, Choi SuJ, Joo EY, et al. The Role of Anterior Thalamic Deep Brain Stimulation as an Alternative Therapy in Patients with Previously Failed Vagus Nerve Stimulation for Refractory Epilepsy. Stereotact Funct Neurosurg. 2019; 97(3): 176–182.
    CrossRefPubMed
  28. Koeppen JA, Nahravani F, Kramer M, et al. Electrical Stimulation of the Anterior Thalamus for Epilepsy: Clinical Outcome and Analysis of Efficient Target. Neuromodulation. 2019; 22(4): 465–471.
    CrossRefPubMed
  29. Herrera ML, Suller-Marti A, Parrent A, et al. Stimulation of the Anterior Nucleus of the Thalamus for Epilepsy: A Canadian Experience. Can J Neurol Sci. 2021; 48(4): 469–478.
    CrossRefPubMed
  30. Järvenpää S, Lehtimäki K, Rainesalo S, et al. Improving the effectiveness of ANT DBS therapy for epilepsy with optimal current targeting. Epilepsia Open. 2020; 5(3): 406–417.
    CrossRefPubMed
  31. Tassigny D, Soler-Rico M, Delavallée M, et al. Anterior thalamic nucleus deep brain stimulation for refractory epilepsy: Preliminary results in our first 5 patients. Neurochirurgie. 2020; 66(4): 252–257.
    CrossRefPubMed
  32. Schaper FL, Plantinga BR, Colon AJ, et al. Deep Brain Stimulation in Epilepsy: A Role for Modulation of the Mammillothalamic Tract in Seizure Control? Neurosurgery. 2020; 87(3): 602–610.
    CrossRefPubMed
  33. Guo W, Koo BB, Kim JH, et al. Defining the optimal target for anterior thalamic deep brain stimulation in patients with drug-refractory epilepsy. J Neurosurg. 2020; 134(3): 1054–1063.
    CrossRefPubMed
  34. Kaufmann E, Bötzel K, Vollmar C, et al. What have we learned from 8 years of deep brain stimulation of the anterior thalamic nucleus? Experiences and insights of a single center. J Neurosurg. 2020 [Epub ahead of print]: 1–10.
    CrossRefPubMed
  35. Tong X, Wang J, Qin L, et al. Analysis of power spectrum and phase lag index changes following deep brain stimulation of the anterior nucleus of the thalamus in patients with drug-resistant epilepsy: A retrospective study. Seizure. 2022; 96: 6–12.
    CrossRefPubMed
  36. Miron G, Strauss I, Fried I, et al. Anterior thalamic deep brain stimulation in epilepsy patients refractory to vagus nerve stimulation: A single center observational study. Epilepsy Behav Rep. 2022; 29(20): 100563.
    CrossRefPubMed
  37. Costa-Gertrudes R, Simão D, Franco A, et al. Anterior Nucleus of Thalamus Deep Brain Stimulation: A Clinical-Based Analysis of the Ideal Target in Drug-Resistant Epilepsy. Stereotact Funct Neurosurg. 2022; 100(2): 108–120.
    CrossRefPubMed
  38. Yan H, Wang X, Zhang X, et al. Deep brain stimulation for patients with refractory epilepsy: nuclei selection and surgical outcome. Front Neurol. 2023; 12(14): 1169105.
    CrossRefPubMed
  39. Peltola J, Colon AJ, Pimentel J, et al. Deep Brain Stimulation of the Anterior Nucleus of the Thalamus in Drug-Resistant Epilepsy in the MORE Multicenter Patient Registry. Neurology. 2023; 100(18): e1852–e1865.
    CrossRefPubMed
  40. Olaciregui Dague K, Witt JA, von Wrede R, et al. DBS of the ANT for refractory epilepsy: A single center experience of seizure reduction, side effects and neuropsychological outcomes. Front Neurol. 2023; 9(14): 1106511.
    CrossRefPubMed
  41. Parisi V, Gregg NM, Lundstrom BN, et al. Temporo-Parietal Extraventricular Approach for Deep Brain Stimulation Targeting the Anterior Nucleus of the Thalamus: Institutional Experience. Neurosurgery. 2023; 93(6): 1393–1406.
    CrossRefPubMed
  42. Sobstyl M, Konopko M, Sienkiewicz-Jarosz H, et al. Clinical efficacy and safety of anterior thalamic deep brain stimulation for intractable drug resistant epilepsy. Epilepsy Res. 2023; 195: 107199.
    CrossRefPubMed
  43. Velasco M, Velasco F, Velasco AL, et al. Acute and chronic electrical stimulation of the centromedian thalamic nucleus: modulation of reticulo-cortical systems and predictor factors for generalized seizure control. Arch Med Res. 2000; 31(3): 304–315.
    CrossRefPubMed
  44. Kulju T, Haapasalo J, Lehtimäki K, et al. Similarities between the responses to ANT-DBS and prior VNS in refractory epilepsy. Brain Behav. 2018; 8(6): e00983.
    CrossRefPubMed
  45. Xu C, Qi L, Wang X, et al. Functional connectomic profile correlates with effective anterior thalamic stimulation for refractory epilepsy. Brain Stimul. 2023; 16(5): 1302–1309.
    CrossRefPubMed
  46. Möttönen T, Katisko J, Haapasalo J, et al. Defining the anterior nucleus of the thalamus (ANT) as a deep brain stimulation target in refractory epilepsy: Delineation using 3 T MRI and intraoperative microelectrode recording. Neuroimage Clin. 2015; 7: 823–829.
    CrossRefPubMed
  47. Lehtimäki K, Möttönen T, Järventausta K, et al. Outcome based definition of the anterior thalamic deep brain stimulation target in refractory epilepsy. Brain Stimul. 2016; 9(2): 268–275.
    CrossRefPubMed
  48. Jiltsova E, Möttönen T, Fahlström M, et al. Imaging of Anterior Nucleus of Thalamus Using 1.5T MRI for Deep Brain Stimulation Targeting in Refractory Epilepsy. Neuromodulation. 2016; 19(8): 812–817.
    CrossRefPubMed
  49. Sudhyadhom A, Haq IU, Foote KD, et al. A high resolution and high contrast MRI for differentiation of subcortical structures for DBS targeting: the Fast Gray Matter Acquisition T1 Inversion Recovery (FGATIR). Neuroimage. 2009; 47 Suppl 2: T44–T52.
    CrossRefPubMed
  50. Wang YC, Grewal SS, Middlebrooks EH, et al. Targeting analysis of a novel parietal approach for deep brain stimulation of the anterior nucleus of the thalamus for epilepsy. Epilepsy Res. 2019; 153: 1–6.
    CrossRefPubMed
  51. Lehtimäki K, Coenen VA, Gonçalves Ferreira A, et al. MORE investigators. The Surgical Approach to the Anterior Nucleus of Thalamus in Patients With Refractory Epilepsy: Experience from the International Multicenter Registry (MORE). Neurosurgery. 2019; 84(1): 141–150.
    CrossRefPubMed
  52. Balak N, Balkuv E, Karadag A, et al. Mammillothalamic and Mammillotegmental Tracts as New Targets for Dementia and Epilepsy Treatment. World Neurosurg. 2018; 110: 133–144.
    CrossRefPubMed
  53. Gross RE, Fisher RS, Sperling MR, et al. Analysis of Deep Brain Stimulation Lead Targeting in the Stimulation of Anterior Nucleus of the Thalamus for Epilepsy Clinical Trial. Neurosurgery. 2021; 89(3): 406–412.
    CrossRefPubMed
  54. Jaseja H. Deep brain stimulation in intractable epilepsy: postulated optimal stimulation parameters. Epilepsy Behav. 2013; 29(3): 597–598.
    CrossRefPubMed
  55. Mirski MA, Rossell LA, Terry JB, et al. Anticonvulsant effect of anterior thalamic high frequency electrical stimulation in the rat. Epilepsy Res. 1997; 28(2): 89–100.
    CrossRefPubMed
  56. Mirski MA, Ferrendelli JA, et al. Interruption of the connections of the mammillary bodies protects against generalized pentylenetetrazol seizures in guinea pigs. J Neurosci. 1987; 7(3): 662–670.
    CrossRefPubMed
  57. Papez JW. A proposed mechanism of emotion. 1937. J Neuropsychiatry Clin Neurosci. 1995; 7(1): 103–112.
    CrossRefPubMed
  58. Oh YS, Kim HJ, Lee KJ, et al. Cognitive improvement after long-term electrical stimulation of bilateral anterior thalamic nucleus in refractory epilepsy patients. Seizure. 2012; 21(3): 183–187.
    CrossRefPubMed
  59. Tröster AI, Meador KJ, Irwin CP, et al. SANTE Study Group. Memory and mood outcomes after anterior thalamic stimulation for refractory partial epilepsy. Seizure. 2017; 45: 133–141.
    CrossRefPubMed
  60. Novais F, Pestana LC, Loureiro S, et al. Predicting de novo psychopathology after epilepsy surgery: A 3-year cohort study. Epilepsy Behav. 2019; 90: 204–208.
    CrossRefPubMed
  61. Van der Werf YD, Witter MP, Groenewegen HJ, et al. The intralaminar and midline nuclei of the thalamus. Anatomical and functional evidence for participation in processes of arousal and awareness. Brain Res Brain Res Rev. 2002; 39(2-3): 107–140.
    CrossRefPubMed
  62. Sadikot AF, Rymar VV, et al. The primate centromedian-parafascicular complex: anatomical organization with a note on neuromodulation. Brain Res Bull. 2009; 78(2-3): 122–130.
    CrossRefPubMed
  63. Zillgitt AJ, Haykal MA, Chehab A, et al. Centromedian thalamic neuromodulation for the treatment of idiopathic generalized epilepsy. Front Hum Neurosci. 2022; 16: 907716.
    CrossRefPubMed
  64. Velasco AL, Velasco F, Jiménez F, et al. Neuromodulation of the centromedian thalamic nuclei in the treatment of generalized seizures and the improvement of the quality of life in patients with Lennox-Gastaut syndrome. Epilepsia. 2006; 47(7): 1203–1212.
    CrossRefPubMed
  65. Velasco F, Velasco M, Ogarrio C, et al. Electrical stimulation of the centromedian thalamic nucleus in the treatment of convulsive seizures: a preliminary report. Epilepsia. 1987; 28(4): 421–430.
    CrossRefPubMed
  66. Fisher RS, Uematsu S, Krauss GL, et al. Placebo-controlled pilot study of centromedian thalamic stimulation in treatment of intractable seizures. Epilepsia. 1992; 33(5): 841–851.
    CrossRefPubMed
  67. Velasco F, Velasco M, Jiménez F, et al. Predictors in the treatment of difficult-to-control seizures by electrical stimulation of the centromedian thalamic nucleus. Neurosurgery. 2000; 47(2): 295–304; discussion 304.
    CrossRefPubMed
  68. Valentín A, García Navarrete E, Chelvarajah R, et al. Deep brain stimulation of the centromedian thalamic nucleus for the treatment of generalized and frontal epilepsies. Epilepsia. 2013; 54(10): 1823–1833.
    CrossRefPubMed
  69. Cukiert A, Cukiert CM, Burattini JA, et al. Seizure outcome during bilateral, continuous, thalamic centromedian nuclei deep brain stimulation in patients with generalized epilepsy: a prospective, open-label study. Seizure. 2020; 81: 304–309.
    CrossRefPubMed
  70. Dalic LJ, Warren AEL, Malpas CB, et al. DBS of Thalamic Centromedian Nucleus for Lennox-Gastaut Syndrome (ESTEL Trial). Ann Neurol. 2022; 91(2): 253–267.
    CrossRefPubMed
  71. Cukiert A, Burattini JA, Cukiert CM, et al. Centro-median stimulation yields additional seizure frequency and attention improvement in patients previously submitted to callosotomy. Seizure. 2009; 18(8): 588–592.
    CrossRefPubMed
  72. Son BC, Shon YM, Choi JG, et al. Clinical Outcome of Patients with Deep Brain Stimulation of the Centromedian Thalamic Nucleus for Refractory Epilepsy and Location of the Active Contacts. Stereotact Funct Neurosurg. 2016; 94(3): 187–197.
    CrossRefPubMed
  73. Kim SH, Lim SC, Yang DW, et al. Thalamo-cortical network underlying deep brain stimulation of centromedian thalamic nuclei in intractable epilepsy: a multimodal imaging analysis. Neuropsychiatr Dis Treat. 2017; 13: 2607–2619.
    CrossRefPubMed
  74. Alcala-Zermeno JL, Gregg NM, Wirrell EC, et al. Centromedian thalamic nucleus with or without anterior thalamic nucleus deep brain stimulation for epilepsy in children and adults: A retrospective case series. Seizure. 2021; 84: 101–107.
    CrossRefPubMed
  75. Torres Diaz CV, González-Escamilla G, Ciolac D, et al. Network Substrates of Centromedian Nucleus Deep Brain Stimulation in Generalized Pharmacoresistant Epilepsy. Neurotherapeutics. 2021; 18(3): 1665–1677.
    CrossRefPubMed
  76. Yang JC, Bullinger KL, Isbaine F, et al. Centromedian thalamic deep brain stimulation for drug-resistant epilepsy: single-center experience. J Neurosurg. 2022; 137(6): 1591–1600.
    CrossRefPubMed
  77. Cukiert A, Cukiert CM, Argentoni-Baldochi M, et al. Intraoperative neurophysiological responses in epileptic patients submitted to hippocampal and thalamic deep brain stimulation. Seizure. 2011; 20(10): 748–753.
    CrossRefPubMed
  78. Warren AEL, Dalic LJ, Bulluss KJ, et al. Targeting the centromedian thalamic nucleus for deep brain stimulation. J Neurol Neurosurg Psychiatry. 2020; 91(4): 339–349.
    CrossRefPubMed
  79. Li J, Li Y, Gutierrez L, et al. Imaging the Centromedian Thalamic Nucleus Using Quantitative Susceptibility Mapping. Front Hum Neurosci. 2019; 9(13): 447.
    CrossRefPubMed
  80. Cukiert A, Lehtimäki K, et al. Deep brain stimulation targeting in refractory epilepsy. Epilepsia. 2017; 58 Suppl 1: 80–84.
    CrossRefPubMed
  81. Morel A. Stereotactic Atlas of the Human Thalamus and Basal Ganglia. New York: Informa Healthcare 2007.

About cookies

Necessary cookies

Allways active

These cookies are necessary for the proper display and operation of the website. Blocking them may cause the website to malfunction.

Analytical cookies

As part of our website, we use analytical tools, such as Google Analytics, that allow us to verify website traffic. These tools may require the use of cookies.

Community cookies

These are cookies associated with the social networks we use. Accepting them will allow us to associate your visit to the site with our social media profiles.

Marketing cookies

These are cookies responsible for carrying out advertising and marketing activities - consenting to their use will allow us to target you with advertisements based on your previous activities within our website.

Neurologia i Neurochirurgia Polska

About Via Medica Advertising
Bookstore (Ikamed) TVMed
News
Copyright © 2023 Via Medica Regulations Cookie policy Privacy policy Legal Notice